ICD-10 Coding for Lymphosarcoma(C77.0, C77.1, C79.89U)
Explore comprehensive ICD-10 coding and documentation guidelines for lymphosarcoma, including mantle cell lymphoma and non-Hodgkin lymphoma classifications.
Complete code families applicable to Lymphosarcoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C83.30 | Mantle cell lymphoma, unspecified site | Use when mantle cell lymphoma is confirmed but the site is unspecified. |
|
| C85.90 | Non-Hodgkin lymphoma, unspecified, unspecified site | Use when the subtype of non-Hodgkin lymphoma is unclear. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutLymphosarcoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Lymphosarcoma.
Coding unspecified lymphoma when subtype is known
Impact
Clinical: May affect treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential for incorrect reimbursement.
Mitigation
Ensure thorough review of pathology reports, Consult with oncologist for subtype confirmation
Using C85.90 when specific subtype is documented
Impact
Reimbursement: May lead to incorrect DRG assignment and financial loss., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.
Mitigation
Use the specific subtype code if available.
Lymphoma Subtype Documentation
Impact
High risk of audit if subtype is not documented.
Mitigation
Ensure all pathology reports are reviewed and subtype is documented.